Marco de Bruyn

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Venues

Nature medicine

British journal of cancer

Journal for immunotherapy of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Anneke L Eerkens, Koen Brummel, Annegé Vledder, Sterre T Paijens, Marta Requesens, Dominik Loiero, Nienke van Rooij, Annechien Plat, Floris-Jan Haan, Patty Klok, Refika Yigit, Thijs Roelofsen, Natascha M de Lange, Rie Klomp, David N Church, Arja Ter Elst, Rene Wardenaar, Diana Carolina Johanna Spierings, Floris Foijer, Viktor Hendrik Koelzer, Tjalling Bosse, Joost Bart, Mathilde Jalving, Anna K L Reyners, Marco de Bruyn, Hans W Nijman
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study. Nature communications 15 (1) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, Catherine Genestie, Etienne Rouleau, Marco de Bruyn, Christophe Klein, Audrey Le Formal, Elodie Edmond, Maëva Moreau, Annechien Plat, Sebastien Gouy, Amandine Maulard, Patricia Pautier, Judith Michels, Ana Oaknin, Emeline Colomba-Blameble, Alexandra Leary
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Anneke L Eerkens, Koen Brummel, Annegé Vledder, Sterre T Paijens, Marta Requesens, Dominik Loiero, Nienke van Rooij, Annechien Plat, Floris-Jan Haan, Patty Klok, Refika Yigit, Thijs Roelofsen, Natascha M de Lange, Rie Klomp, David N Church, Arja Ter Elst, Rene Wardenaar, Diana Carolina Johanna Spierings, Floris Foijer, Viktor Hendrik Koelzer, Tjalling Bosse, Joost Bart, Mathilde Jalving, Anna K L Reyners, Marco de Bruyn, Hans W Nijman
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study. Nature communications 15 (1) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, Catherine Genestie, Etienne Rouleau, Marco de Bruyn, Christophe Klein, Audrey Le Formal, Elodie Edmond, Maëva Moreau, Annechien Plat, Sebastien Gouy, Amandine Maulard, Patricia Pautier, Judith Michels, Ana Oaknin, Emeline Colomba-Blameble, Alexandra Leary
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Arjan Kol, Xiaoyu Fan, Marta A Wazynska, Sander M J van Duijnhoven, Danique Giesen, Annechien Plat, Hans Van Eenennaam, Philip H Elsinga, Hans W Nijman, Marco de Bruyn
Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration. Journal for immunotherapy of cancer 10 (12) (2023)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Prognostic benefit of TILs independent of clinicopathological and molecular factors. British journal of cancer (2023)
Xiaoyu Fan, Marta A Ważyńska, Arjan Kol, Noemi Perujo Holland, Bruna Fernandes, Sander M J van Duijnhoven, Annechien Plat, Hans van Eenennaam, Philip H Elsinga, Hans W Nijman, Marco de Bruyn
Development of [ 89 Zr]Zr-hCD103.Fab01A and [ 68 Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET. EJNMMI research 13 (1) (2023)
Arjan Kol, Xiaoyu Fan, Marta A Wazynska, Sander M J van Duijnhoven, Danique Giesen, Annechien Plat, Hans Van Eenennaam, Philip H Elsinga, Hans W Nijman, Marco de Bruyn
Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration. Journal for immunotherapy of cancer 10 (12) (2023)
Arjan Kol, Xiaoyu Fan, Marta A Wazynska, Sander M J van Duijnhoven, Danique Giesen, Annechien Plat, Hans Van Eenennaam, Philip H Elsinga, Hans W Nijman, Marco de Bruyn
Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration. Journal for immunotherapy of cancer 10 (12) (2023)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer (2022)
Christy Hong, Michael Schubert, Andréa E Tijhuis, Marta Requesens, Maurits Roorda, Anouk van den Brink, Lorena Andrade Ruiz, Petra L Bakker, Tineke van der Sluis, Wietske Pieters, Mengting Chen, Rene Wardenaar, Bert Van der Vegt, Diana Carolina Johanna Spierings, Marco de Bruyn, Marcel A T M van Vugt, Floris Foijer
cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607 (7918) (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer 128 (3) (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer (2022)
Nanda Horeweg, Hagma H Workel, Dominik Loiero, David N Church, Lisa Vermij, Alicia Léon-Castillo, Ricki T Krog, Stephanie M de Boer, Remi A Nout, Melanie E Powell, Linda R Mileshkin, Helen MacKay, Alexandra Leary, Naveena Singh, Ina M Jürgenliemk-Schulz, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Hans W Nijman, Tjalling Bosse, Marco de Bruyn, null null
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. Nature communications 13 (1) (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer 128 (3) (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer 128 (3) (2022)

Marco de Bruyn.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco de Bruyn